Labeling of low-density lipoproteins using the 18F-labeled thiol-reactive N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide

被引:82
作者
Berndt, Mathias [1 ]
Pietzsch, Jens [1 ]
Wuest, Frank [1 ]
机构
[1] Res Ctr Rossendorf, Inst Radiopharm, D-01314 Dresden, Germany
关键词
positron emission tomography; F-18-labeled prosthetic group; LDL; lipoprotein modification; HUMAN APOLIPOPROTEIN-E; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; N-SUCCINIMIDYL; BINDING DOMAIN; GENERAL-METHOD; F-18; PROTEINS; OLIGONUCLEOTIDES; RECEPTOR;
D O I
10.1016/j.nucmedbio.2006.09.009
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The novel thiol-group-selective bifunctional F-18-labeling agent N-[6-(4-[F-18]fluoro-benzylidene)aminooxyhexyl]maleimide ([F-18]FBAM) has been developed. The bifunctional labeling precursor N-(6-aminoxyhexyl)maleimide containing a thiol-reactive maleimide group and a carbonyl-group-reactive aminooxy group was prepared in only three steps in a total chemical yield of 59%. Subsequent radiolabeling with 4-[F-18]fluorobenzaldehyde gave the bifunctional F-18-labeling agent [F-18]FBAM in a radiochemical yield of 29%. In a typical experiment, 3.88 GBq of [F-18]fluoride could be converted into 723 MBq of [F-18]FBAM within 69 min. Conjugation of [F-18]FBAM with thiol groups was exemplified with the cystein-containing tripeptide glutathione and with various apolipoproteins of human low-density lipoprotein (LDL) subfractions. The latter was evaluated with respect to the uptake of [F-18]FBAM-LDL subtractions in human hepatoma cells (HepG2) in vitro. In vivo biodistribution studies in rats revealed high stability for [F-18]FBAM-LDL subtractions. Moreover, the metabolic fate of [F-18]FBAM-LDL subtractions in vivo was delineated by dynamic positron emission tomography studies using a dedicated small animal tomograph. Data were compared to former studies that used the NH2-reactive F-18-labeling agent N-succinimidyl-4-[F-18]fluorobenzoate. The compound [F-18]FBAM can be considered as an excellent prosthetic group for the selective and mild F-18 labeling of thiol-group-containing biomolecules suitable for subsequent investigations in vitro and in vivo. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:5 / 15
页数:11
相关论文
共 44 条
[21]   Fluorine-18 labeling of peptide nucleic acids [J].
Kuhnast, B ;
Dolle, F ;
Tavitian, B .
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2002, 45 (01) :1-11
[22]  
Kuhnast B, 2000, J LABELLED COMPD RAD, V43, P837, DOI 10.1002/1099-1344(200007)43:8<837::AID-JLCR368>3.0.CO
[23]  
2-2
[24]   Module-assisted synthesis of the bifunctional labelling agent N-succinimidyl 4-[18F]fluorobenzoate ([18F]SFB) [J].
Mäding, P ;
Füchtner, F ;
Wüst, F .
APPLIED RADIATION AND ISOTOPES, 2005, 63 (03) :329-332
[25]   Catabolism of native and oxidized low density lipoproteins:: in vivo insights from small animal positron emission tomography studies [J].
Pietzsch, J ;
Bergmann, R ;
Wuest, F ;
Pawelke, B ;
Hultsch, C ;
van den Hoff, J .
AMINO ACIDS, 2005, 29 (04) :389-404
[26]   Fluorine-18 radiolabeling of low-density lipoproteins: a potential approach for characterization and differentiation of metabolism of native and oxidized low-density lipoproteins in vivo [J].
Pietzsch, J ;
Bergmann, R ;
Rode, K ;
Hultsch, C ;
Pawelke, B ;
Wuest, F ;
van den Hoff, J .
NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (08) :1043-1050
[27]   VERY FAST ULTRACENTRIFUGATION OF SERUM-LIPOPROTEINS - INFLUENCE ON LIPOPROTEIN SEPARATION AND COMPOSITION [J].
PIETZSCH, J ;
SUBAT, S ;
NITZSCHE, S ;
LEONHARDT, W ;
SCHENTKE, KU ;
HANEFELD, M .
BIOCHIMICA ET BIOPHYSICA ACTA-LIPIDS AND LIPID METABOLISM, 1995, 1254 (01) :77-88
[28]   Analysis of 6-hydroxy-2-aminocaproic acid (HACA) as a specific marker of protein oxidation:: The use of N(O,S)-ethoxycarbonyl trifluoroethyl ester derivatives and gas chromatography/mass spectrometry [J].
Pietzsch, J ;
Bergmann, R .
AMINO ACIDS, 2004, 26 (01) :45-51
[29]   Different susceptibility to oxidation of proline and arginine residues of apolipoprotein B-100 among subspecies of low density lipoproteins [J].
Pietzsch, J ;
Julius, U .
FEBS LETTERS, 2001, 491 (1-2) :123-126
[30]  
Rennen HJJM, 2001, Q J NUCL MED, V45, P167